You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company published a letter on its website explaining that the genetic and other analyses involved in its services were too costly for customers to support.
The company is working with partners to identify new biomarkers and treatments as well as to collect utility evidence for its current coaching model.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
The company is offering introductory pricing on Helix services for heart health and weight loss, and has shifted its flagship program from a yearly subscription to a monthly option.
Researchers reported on results for more than 100 healthy individuals who were tracked with 'omics and clinical tests over nine months.
The company, still collecting utility data, anticipates that this more complex analysis will lead to better personalization of health and wellness strategies for its clients.
In a panel at this week's Personalized Medicine World Conference, executives and researchers discussed moving genomics into the promotion of lifetime health and prevention of disease.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.
Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.
CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.
In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.